Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Observational

Cohort of Chronic Pain Patients

NCT04880096 · tracked via the Priya Life Science France tracker
Phase
Observational
Started
2021-09-14
Last updated
2026-04-01

Condition(s) studied

Chronic Pain

Investigational drug(s) / intervention(s)

eDOL

eDOL: e-health tool (mobile app for patients and web platform for caregivers in pain clinics)

Study summary

Chronic pain affects approximately 20% of adults, 50% of the elderly population and over 1.5 billion people worldwide. Societal and economic issues are also crucial, as 60% of people with pain are less able or unable to work and 20% say they have lost their jobs because of pain. The overall cost of chronic pain is estimated at around 300 billion euros in the EU. Unfortunately, current treatments for chronic pain have limited effectiveness and important adverse effects. Pain clinics, which support the most complex and refractory cases of chronic pain, as well as general practitioners and patients expect improvements, both in terms of therapeutic efficacy and organization of care.

In order to allow the characterization and a personalized follow-up of chronic pain patients, we have created e-DOL, a smartphone application for patients and a web platform for healthcare professionals in pain clinics. The purpose of this study is to create an e-cohort for the research, and characterization and follow-up of chronic pain patients.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * All patients with chronic pain * patients equipped and regular users of a smartphone * Non-opposition to participation in the study Exclusion Criteria: * Patient unable to understand or answer questionnaires

Primary outcome measure(s)

  • multidimensional characterisation of chronic pain patients — 5 years
    Multimodal exploratory analysis of the determinants and repercussions of chronic pain, and their evolution in a real-life context, taking into account all environmental events likely to influence chronic pain (treatments, history, co-morbidities, etc.).

Trial sites (22)

FacilityCityRegionStatus
CHU de Clermont-Ferrand - Service de Neurologie Clermont-Ferrand AURA Recruiting
Clermont-Ferrand University Hospital Clermont-Ferrand AURA Recruiting
APHP Ambroise Paré Boulogne-Billancourt IDF Recruiting
APHP Saint Antoine Paris IDF Recruiting
APHP Cochin Paris IDF Recruiting
Groupe Hospitalier Paris Saint Joseph Paris IDf Recruiting
CHU Amiens Amiens France Recruiting
CH Bayeux Bayeux France Not Yet Recruiting
CHU bordeaux Bordeaux France Not Yet Recruiting
Hospices civils Lyon Bron France Recruiting
CHU Grenoble Grenoble France Recruiting
CHU Limoges Limoges France Recruiting
Ch Lons Le Saunier Lons-le-Saunier France Recruiting
CHU Montepllier Montpellier France Not Yet Recruiting
CHU Nantes Nantes France Recruiting
CHU Nîmes Nîmes France Recruiting
CHU Rennes Rennes France Recruiting
Chu Rouen Rouen France Recruiting
CHU Saint Etienne Saint-Etienne France Recruiting
Hôpital Civil de Strasbourg Strasbourg France Recruiting
Chu Toulouse Toulouse France Recruiting
CH Voiron Voiron France Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04880096 on ClinicalTrials.gov ↗ ← All trials in France